OS Therapies (OSTX)
NYSE: OSTX
· Real-Time Price · USD
2.06
-0.09 (-4.19%)
At close: Aug 15, 2025, 3:59 PM
2.07
0.24%
Pre-market: Aug 18, 2025, 05:22 AM EDT
OS Therapies Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q1 2022 | Q4 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Mar 31, 2022 | Dec 31, 2021 |
Cash & Equivalents | 2.97M | 5.53M | 1.86M | 94.92K | 100.23K | 38.98K | 16.06K | 355.21K | 171.48K | n/a | 80.79K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -80.79K | n/a |
Receivables | 23.64K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | n/a | 77.5K | 1.18M | 941.34K | 751.05K | 629.47K | 583.77K | 325.36K | n/a | 232.03K |
Total Current Assets | 4.1M | 5.53M | 1.97M | 1.34M | 1.04M | 790.03K | 645.53K | 938.99K | 496.83K | 80.79K | 312.81K |
Property-Plant & Equipment | 4.58K | 5.27K | 6.66K | 6.66K | 7.36K | 8.05K | 8.07K | 12.17K | 12.27K | n/a | 13.08K |
Goodwill & Intangibles | 150K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 154.57K | 5.27K | 6.66K | 6.66K | 7.36K | 8.05K | 8.07K | 12.17K | 12.27K | -80.79K | 13.08K |
Total Assets | 4.25M | 5.54M | 1.98M | 1.34M | 1.05M | 798.08K | 653.6K | 951.16K | 509.11K | n/a | 325.89K |
Account Payables | 1.62M | 1.66M | 1.77M | 2.92M | 2.8M | 2.72M | 2.54M | 1.77M | 1.23M | n/a | 856.52K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | 16.7M | 15.56M | 14.61M | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 1.92M | 1.97M | 130K | 5.46M | 5.19M | 4.71M | 4.68M | 3.64M | 3.26M | n/a | 1.71M |
Total Current Liabilities | 3.54M | 4.63M | 2.58M | 28.31M | 26.46M | 24.71M | 9.41M | 7.31M | 6.15M | n/a | 3.5M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | 13.54M | 11.39M | 10.35M | n/a | 7.07M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | 230K | 987.6K | 1.57M | 11.45M | 1.21M |
Total Long-Term Liabilities | n/a | 100K | 100K | 100K | 100K | 100K | 13.77M | 12.38M | 11.92M | 11.45M | 8.28M |
Total Liabilities | 3.54M | 4.73M | 2.68M | 28.41M | 26.56M | 24.81M | 23.17M | 19.69M | 18.07M | 11.45M | 11.78M |
Total Debt | n/a | n/a | n/a | 16.7M | 15.56M | 14.61M | 13.54M | 11.39M | 10.35M | n/a | 7.07M |
Common Stock | 21.35K | 20.87K | 21.18K | 5.99K | 5.99K | 5.34K | 10.68K | 10.68K | 9.98K | n/a | 9.98K |
Retained Earnings | -42.31M | -40.4M | -35.44M | -32.57M | -31.01M | -29.52M | -28.02M | -23.48M | -21.6M | n/a | -15.22M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11.45M | n/a |
Shareholders Equity | 613.67K | 811.49K | -707.13K | -27.06M | -25.51M | -24.02M | -22.52M | -18.74M | -17.56M | -11.45M | -11.45M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |